Memorializing Governor Kathy Hochul to proclaim the month of May 2026, as Hepatitis B Awareness Month in the State of New York
Assembly Resolution 1398 is a memorializing resolution that urges Governor Kathy Hochul to proclaim May 2026 as Hepatitis B Awareness Month in New York State. The resolution does not create a new program, mandate, or regulatory requirement; instead, it is a formal legislative statement highlighting the public health importance of hepatitis B and encouraging public education about its causes, symptoms, diagnosis, prevention, and treatment.
The resolution emphasizes that hepatitis B is a serious liver infection that can become chronic and lead to cirrhosis or liver cancer, with particular concern for infants and other people who may be unaware they are infected. It cites New York’s high hepatitis B burden, including a significant concentration in Queens County, and points to the importance of vaccination, screening, and treatment access as the most effective tools for prevention and disease management. The measure also references national changes in hepatitis B birth-dose recommendations and argues that awareness remains especially important in light of gaps in screening and linkage to care.
Because this is a resolution rather than a bill amending the Public Health Law or another statute, it has no direct legal effect on state law, agency authority, or private rights. Its practical impact is symbolic and educational: it seeks to elevate public awareness, encourage vaccination and screening, and reinforce public health messaging around hepatitis B prevention and treatment in New York. The resolution may also support advocacy efforts by public health organizations and providers working with affected communities, especially in areas with higher prevalence.
The overall sentiment reflected in the resolution is strongly supportive of hepatitis B awareness, prevention, and vaccination. The tone is public-health oriented and precautionary, stressing the seriousness of the disease and the value of early intervention. No committee debate or recorded votes are available in the provided materials, so there is no evidence of opposition in the record supplied; the measure appears to be a consensual awareness resolution.
No direct contention is documented in the provided transcript or voting history, since none is available. The only potentially sensitive policy issue raised by the text is the emphasis on universal hepatitis B birth-dose vaccination and concern about recent changes to national recommendations, which the resolution implicitly critiques by arguing that delaying or limiting vaccination could increase preventable infections. Any disagreement would likely center on vaccination policy, screening practices, or the balance between universal and risk-based approaches, but no specific legislators or stakeholders are identified in the materials.